We are committed to respecting intellectual property rights (IPR) and safeguarding both our own and our partners’ IPR. We do not supply products in regions where they could potentially infringe upon existing IPR of third parties.
Neuland has an intellectual property rights group that assesses IP matters and focuses on adding capabilities to APIs.
Intellectual property expertise
- IP policies & IP strategies
- White space analysis
- Identification of early launch opportunities
- Finalization of the non-infringing synthetic routes for APIs & peptides
- Protecting the company’s invention across the globe
- IP commercialization
- Handling IP-related queries
Our extensive portfolio of approvals, backed by R&D, offers several patented non-infringing processes and intellectual properties, while our cost-effective mega-manufacturing facilities comply with regulatory standards. We are constantly developing technologies to come up with innovative processes.
We have an experienced team of IP attorneys and professionals, specialized in related fields of science and IP law, working to ensure the protection of IP wealth created by Neuland.
IPR awards received
- ASSOCHAM – Best Patent Portfolio Award for FY2023
- Legal Era - Best In-house Team Award for FY2023
- ASSOCHAM – Best Patent Portfolio Award for FY2022
- ASSOCHAM – IP Excellence Award for FY2021
- GIPC award for best IPR team for FY2020
- NITI Aayog award for IP excellence in patents for FY2020
- NITI Aayog award for IP Leadership in the field of patent for FY2020
- De-science award for IP excellence of India for FY2018
- De-science award for IP gems of India for FY2018
- Silver Patent Award from Pharmaexcil (Govt of India) under bulk drug category for FY2016
Regulatory CMC Support
Quality Control & Assurance
